Audit of therapeutic interventions in inpatient children using two scores: Are they evidence-based in developing countries?

BMC Health Services Research

Volumn 4, Issue , 2004, Pages

  Carreazo, Nilton Y ^a   Bada, Carlos A ^a   Chalco, Juan P ^a   Huicho, Luis ^a  

^a UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALBENDAZOLE; AMIKACIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAPTOPRIL; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; ETAFEDRINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INFUSION FLUID; LANATOSIDE C; MEBENDAZOLE; OXACILLIN; PARACETAMOL; PENICILLIN G SODIUM; PHENYTOIN; SPIRONOLACTONE; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; ASTHMA; BACTERIAL MENINGITIS; BRAIN DISEASE; BRONCHIOLITIS; CELLULITIS; CLASSIFICATION; COMMUNITY ACQUIRED PNEUMONIA; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CYANOSIS; DEHYDRATION; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE SEVERITY; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; HEMOPHILIA A; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MEDICAL AUDIT; MEDICAL EXPERT; MEDICAL RECORD; OTITIS MEDIA; PANCREATITIS; PATIENT REFERRAL; PNEUMONIA; SCORING SYSTEM; SYSTEMATIC REVIEW; TRICHURIASIS; URINARY TRACT INFECTION; CHILD; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; HOSPITALIZED CHILD; PERU; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; UNIVERSITY HOSPITAL;

CHILD; CHILD, HOSPITALIZED; COMMUNITY-ACQUIRED INFECTIONS; DEHYDRATION; DEVELOPING COUNTRIES; DIARRHEA; EVIDENCE-BASED MEDICINE; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; MEDICAL AUDIT; PERU; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION;

EID: 14544294467     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-4-40     Document Type: Article

References (50)

1. Office of Technology Assessment of the Congress of the United States: Assessing the efficacy and safety of medical technologies Washington, DC: US Government Printing Office; 1978.
2. Dubinsky M, Ferguson JH: Analysis of the National Institutes of Health Medicare Coverage Assessment. Int J Technol Assess Health Care 1990, 6:480-488.
3. Ellis J, Mulligan I, Rowe J, Sackett DL: Inpatient general medicine is evidence based. Lancet 1995, 346:407-410.
4. Gill P, Dowell AC, Neall RD, Smith N, Heywood P, Wilson AE: Evidence based general practice: a retrospective study of interventions in one training practice. BMJ 1996, 312:819-821.
5. Kenny SE, Shankar KR, Rintala R, Lamont GL, Lloyd DA: Evidence based surgery: interventions in a regional paediatric surgical unit. Arch Dis Child 1997, 76:50-55.
6. Rudolf MC, Lyth N, Bundle A, Rowland G, Kelly A, Bosson S: A search for the evidence supporting community paediatric practice. Arch Dis Child 1999, 80:257-261.
7. Curley AE, Tubman TR, Halliday HL: Tratamiento de los recién nacidos de muy bajo peso al nacer ¿Se basa en la evidencia? An Esp de Ped 2000, 52:554-560.
8. Moyer VA, Gist AK, Elliott AJ: Is the practice of paediatric inpatient medicine evidence based? J Paediatr Child Health 2002, 38:347-351.
9. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, the Bellagio Child Survival Study Group: How many child deaths can we prevent this year? Lancet 2003, 362:65-71.
10. The Bellagio Study Group on Child Survival: Knowledge into action for child survival. Lancet 2003, 362:323-27.
11. Naylor CD, Guyatt G: Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. JAMA 1996, 275:1435-1439.
12. Levels of Evidence and Grades of Recommendation [http://www.cebm.net/ levels_of_evidence.asp]
13. Asthma and Other Wheezing Disorders in Children [http://www. clinicalevidence.com/ceweb/conditions/chd/0302/0302.jsp]
14. Bronchiolitis [http://www.clinicalevidence.com/ceweb/conditionpdf/0308. pdf]
15. American Academy of Pediatrics: The Neurodiagnostic Evaluation of the Child with a First Simple Febrile Seizure. Pediatrics 1996, 97:769-775.
16. Stevens D, Smith L, Bruss J, et al.: Randomized comparison of Linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemoter 2000, 44:3408-3413.
17. Acute Otitis Media [http://www.clinicalevidence.com/ceweb/conditionpdf/ 0301.pdf]
18. Osmond M, Evans D: Croup. In In Clinical Evidence: A compendium of the best available evidence for effective health care Edited by: Godlee F. London. BMJ Publishing Group; 2000:195-205.
19. Jongsuksuntigul P, Jeradit C, Pornpattanakul S, Charanasri U: A comparative study on the efficacy of albendazole and mebendazole in the treatment of ascariasis, hookworm infection and trichuriasis. Southeast Asian J Trop Med Public Health 1993, 24:724-729.
20. Armon K, Stephenson T, MacFaul R, Eccleston P, Werneke U: An evidence and consensus based guideline for acute diarrhoea management. Arch Dis Child 2001, 85:132-142.
21. British Thoracic Society of Standards of Care Committee: BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002:i1-24.
22. Uretsky BF, Pina I, Quigg RJ, Brill JV, MacInerney EJ, Mintzer R, Armstrong PW: Beyond drug therapy: Non-pharmacologic care of the patient with advanced heart failure. Am Heart J 1998, 135:264-284.
23. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J, for The Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709-717.
24. Rheuban KS, Carpenter MA, Ayers CA, Gutgesell HP: Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure. J Pediatr 1990, 117:668-670.
25. Krasnoff AR, Mangione RA: Blood products used in the treatment of hemophilia. Hosp Pharm 1982, 17:598-599.
26. Smith M: Cyanosis in the infant. In In Handbook of Pediatric Emergencies 3rd edition. Edited by: Baldwin G. Philadelphia: Lippincott Williams and Wilkins; 2001:277-280.
27. Zar H, Cotton M: Nosocomial pneumonia in pediatric patients. Practical problems and rational solutions. Pediatr Drugs 2002, 4:73-83.
28. Guideline for the management of acute and chronic pain in sickle cell disease [http://www.guidelines.gov/summary/summary.aspx?doc_id=2621&nbr= 1847&string=sickle-cell+AND+anemia]
29. Krishna Kumar R: A Practical approach for the diagnosis and management of dilated cardiomyopathy. Indian J Pediatr 2002, 69:341-350.
30. Bengur AR, Beekman RH, Rochini AP, Crowley DC, Schork MA, Rosenthal A: Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation 1991, 83:523-527.
31. Canadian Pediatric Society Statement: Management of the pediatric patient with generalized convulsive status epilepticus in the emergency department. Pediatrics & Child Health 1996, 1:151-155.
32. Appleton R, Martland T, Phillips B: Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children (Cochrane Review). In In: The Cochrane Library Issue 1 Oxford: Update Software; 2003.
33. El Bashir H, Laundy M, Booy R: Diagnosis and treatment of bacterial meningitis. Arch Dis Child 2003, 88:615-620.
34. World Health Organization: The management of bloody diarrhoea in young children Geneva; WHO/CDD/94.49; 1994.
35. Pisani E, Bartoletti R, Trinchieri A, Rizzo M: Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. J Chemother 1996, 8:210-213.
36. Al-Omran M, Groof A, Wilke D: Enteral versus parenteral nutrition for acute pancreatitis (Cochrane Review). In In: The Cochrane Library Issue 1 Oxford: Update Software; 2003.
37. Pietzak M, Thomas D: Pancreatitis in childhood. Pediatr Rev 2000, 21:406-412.
38. Mayumi T, Ura H, Arata S, Kitamura N, Kiriyama I, Shibuya K, Sekimoto M, Nago N, Hirota M, Yoshida M, Ito Y, Hirata K, Takada T, Working Group for the Practical Guidelines for Acute Pancreatitis. Japanese Society of Emergency Abdominal Medicine: Evidence-based clinical practice guidelines for acute pancreatitis: proposals. J Hepatobiliary Pancreat Surg 2002, 9:413-422.
39. Beamon RF, Siegel CJ, Landers G, Green V: Hydrocarbon ingestion in children: a six-year retrospective study. JACEP 1976, 5:771-775.
40. Mencías E: Intoxicaciones por productos industriales: hidrocarburos. JANO Medicina y Humanidades 1998, 54:38-42.
41. DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC, The Adenosine for PSVT Study Group: Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. Ann Intern Med 1990, 113:104-110.
42. Jacobson SJ, Griffiths K, Diamond S, Winders P, Sgro M, Feldman W, Macarthur C: A randomized controlled trial of penicillin vs clindamycin for the treatment of aspiration pneumonia in children. Arch Pediatr Adolesc Med 1997, 151:701-704.
43. Daaboul Y, Vern BA, Blend MJ: Brain SPECT imaging and treatment with IVIG in acute post-infectious cerebellar ataxia: case report. Neurol Res 1998, 20:85-88.
44. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I: Idiopathic Thrombocytopenic Purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996, 88:3-40.
45. Sonmez K, Demirogullari B, Ekingen G, Turkyilmaz Z, Karabulut R, Basaklar AC, Kale N: Randomized, placebo-controlled treatment of anal fissure by lidocaine, EMLA, and GTN in children. J Pediatr Surg 2002, 37:1313-1316.
46. Kenny SE, Irvine T, Driver CP, Nunn AT, Losty PD, Jones MO, Turnock RR, Lamont GL, Lloyd DA: Double blind randomized controlled trial of topical glyceryl trinitrate in anal fissure. Arch Dis Child 2001, 85:404-407.
47. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF: The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995, 96:1057-1061.
48. Masaru T, Stanford S: Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997, 131:888-893.
49. Reduced Osmolarity Oral Rehydration Salts (ORS) Formulation. Report from a Meeting of Experts Jointly Organized by UNICEF and WHO [http://www.who.int/ child-adolescenthealth/New_Publications/NEWS/Expert_consultation.htm]
50. World Health Organization: Acute respiratory infections in children: case management in small hospitals in developing countries Geneva; WHO/ARI90.5; 1990.